Impact of systemic manifestations/comorbidities on clinical state, prognosis and utilisation of health care resources in patients with COPD-COSYCONET2
- Conditions
- J44.8J44.9Other specified chronic obstructive pulmonary diseaseChronic obstructive pulmonary disease, unspecified
- Registration Number
- DRKS00015884
- Lead Sponsor
- Philipps-Universität Marburg
- Brief Summary
Not available
- Detailed Description
Not available
Recruitment & Eligibility
- Status
- Recruiting
- Sex
- All
- Target Recruitment
- 600
1. male or female, 2. 40 years old and older 3. Diagnosis COPD (GOLD 1 - 4) or 4. smoker or ex smoker with minimal 10 packyears and normal lungfunction (FEV1/FVC > =0.7 after bronchodilatation) and symptoms (>= 10 in CAT questionnaire or >= 2 in mMRC scale) or inhale minimal one bronchodilatator.
5. signed informed consent
6. cognitive and physical ability to meet the demands of the study protocol
Having undergone lung surgery (e.g. lung volumen reduction, lung transplant)
Patients with lung cancer under treatment
Moderate or severe exacerbation within the last 4 weeks
Unable to understand the intention of the project,
former member of COSYCONET
Study & Design
- Study Type
- observational
- Study Design
- Not specified
- Primary Outcome Measures
Name Time Method Main outcome will be the multidimensional BODE-Score: however in COSYCONET-2 this score lays not in the focus of interest. Instead the aim is to answer many specific questions with specific disease entities and specific markers.
- Secondary Outcome Measures
Name Time Method